Cancer Therapy Advisor (3/7, Mistry) reported that “a web-based program called ‘WRITE Symptoms’ can improve symptom control for patients with recurrent ovarian cancer, according to a study” that “enrolled 497 patients with recurrent or persistent ovarian, fallopian, or primary peritoneal cancer who had 3 or more symptoms.” The study findings published in the Journal of Clinical Oncology revealed […]
MedPage Today (2/23, Bankhead) reported, “Secondary cytoreductive surgery (SCS) for recurrent ovarian cancer significantly improved overall survival…when surgery achieved maximal tumor resection, a large meta-analysis showed.” According to the results published in the Journal of Clinical Oncology, “pooled data from 36 studies showed a death rate of 44.2%, which decreased substantially with increasing rates of complete and optimal SCS.” […]
MedPage Today (2/7, Bassett) reported, “COVID-19 mRNA vaccination is just as safe for people with cancer as it is for cancer-free individuals, according to a prospective, single-institution observational study.” Investigators found that “among a cohort of over 1,700 patients, more than two-thirds of whom had a history of cancer, local pain at the injection site was […]
Healio (1/21) reported, “Coffee consumption may reduce the risk for endometrial cancer, according to a study.” The findings were published in The Journal of Obstetrics and Gynaecology Research. […]
Healio (1/24, Marabito) reported, “The proportion of women in the U.S. who were not up to date on recommended cervical cancer screening significantly increased from 2005 to 2019, according to” study findings. The research was published in JAMA Network Open. […]
STAT (2/1, Chen) reported research “suggests that by analyzing cervical cells’ genomes, researchers might be able to find genetic signatures that predict the risk of ovarian, breast, and endometrial cancers and flag patients that should be screened more aggressively.” Investigators “examined samples from cervical smears of roughly 2,000 women” and then “used that data to train an […]
MedPage Today (1/6) reported, “More than 70% of women with high-risk early ovarian cancer had one or more symptoms of underlying disease, most often abdominal or pelvic pain, a large retrospective review showed.” The findings were published in Obstetrics & Gynecology. […]
CNN (1/12, McPhillips) reported, “Cancer mortality rates have been dropping for nearly two decades, aided by ‘major progress’ in the early detection and treatment options for lung cancer, according to the American Cancer Society’s annual report on cancer statistics.” The data indicated that “the overall cancer death rate dropped by about a third (32%) from its peak in 1991 […]
Healio (1/6) reported, “High-grade vulvar, vaginal and anal precancer rates decreased or stabilized after the introduction of the HPV vaccine, according to findings.” The study results were published in the American Journal of Preventive Medicine. […]
MedPage Today (12/1, Bankhead) reported, “A novel immunotherapy provided durable disease control in homologous repair proficient (HRP) ovarian cancer, subgroup data from a small randomized trial showed.” After three years of surveillance, the “median overall survival (OS) had yet to be reached in patients who received gemogenovatucel-T (Vigil), but appeared to exceed 41 months, as compared with […]